EUVIMEDEUVIMED entdecken
Crossref

Patient experiences of access to NCD medicines in Sri Lanka: Evidence of the success story towards universal coverage

BMR Fernandopulle, Nalika Gunawardena, SHP de Silva, Chinta Abayawardana, LK Hirimuthugoda

Medicine Access @ Point of Care · 2019

DOI: 10.1177/2399202619873228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine Access @ Point of Care, 2019. Verfasst von BMR Fernandopulle und 4 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In Sri Lanka in 2013, 16 medicines were identified as priority to manage non-communicable disease (NCD), and in 2017, 48 NCD medicines were price-regulated.

Objective

The aim of the present study was to describe the experiences on availability of drugs and out-of-pocket expenditure (OOPE) for drugs among patients with NCDs in Sri Lanka.

Methods

This community-based, household survey was conducted in nine districts of the country. The survey included 1100 adults (aged 50 years and above) with a diagnosis of NCD for 5 years. They were interviewed by trained pharmacy students.

Results

Approximately 66%, 49% and 21.6% suffering from hypertension, diabetes and ischaemic heart disease, respectively, with a majority having more than one NCD. The evidence showed that prescribers align to drugs that have been recognized to be made more available and more affordable. Of all, 14% had prescriptions with all NCD medicines classified in the list, while 40% had only one or two of the drugs prescribed which are not in the list. Most of the prescribed drugs were also included in the price regulation – with 29% having all medicines included, while 31.6% having only one or two drugs prescribed out of the list. Approximately, two-thirds (64.2%) had exclusively used government hospitals for NCD care during the past 5 years. A majority (58.3%) had all prescribed drugs available at the last visit to the state sector clinic, while almost all of the others (35.7%) had some of the drugs available.

Conclusion

The study concluded that patient experiences in Sri Lanka showed good availability and access to NCD medicines in Sri Lanka.

Zitieren

APA

Fernandopulle, B., Gunawardena, N., Silva, S. D., Abayawardana, C., & Hirimuthugoda, L. (2019). Patient experiences of access to NCD medicines in Sri Lanka: Evidence of the success story towards universal coverage. Medicine Access @ Point of Care. https://doi.org/10.1177/2399202619873228

Vancouver

Fernandopulle B, Gunawardena N, Silva SD, Abayawardana C, Hirimuthugoda L. Patient experiences of access to NCD medicines in Sri Lanka: Evidence of the success story towards universal coverage. Medicine Access @ Point of Care. 2019. doi:10.1177/2399202619873228

BibTeX
@article{Fernandopulle2019,
  author = {Fernandopulle, BMR and Gunawardena, Nalika and Silva, SHP de and Abayawardana, Chinta and Hirimuthugoda, LK},
  title = {Patient experiences of access to NCD medicines in Sri Lanka: Evidence of the success story towards universal coverage},
  journal = {Medicine Access @ Point of Care},
  year = {2019},
  doi = {10.1177/2399202619873228}
}
Kostenlos starten →